TY - JOUR
T1 - Economic burden of Community-acquired pneumonia and invasive pneumococcal diseases in elderly: the Italian situation
AU - Capizzi, Silvio
AU - Veneziano, Maria Assunta
AU - Specchia, Maria Lucia
AU - Sferrazza, Antonella
AU - Kheiraoui, F
AU - De Waure, Chiara
AU - Ferriero, Anna Maria
AU - La Torre, Giuseppe
AU - Ricciardi, Walter
PY - 2012
Y1 - 2012
N2 - Background: Streptococcus pneumoniae (Spn) is the most common
cause of Community-acquired pneumonia (CAP) and invasive
pneunmococcal diseases (IPD) in the elderly population.
Objectives: The objective of the analysis was to estimate the
economic burden of disease caused by Spn in Italy by considering
people aged > 65 years.
Methods: A cost of illness analysis was performed from the Italian
National Health Service (NHS) perspective. Therefore, only direct medical costs were taken into account. The main cost drivers were as
follows: diagnosis, visits to GPs, drugs, hospitalizations. Regarding
epidemiological and economic data input, incidence rates were taken
from the national literature and unit costs (€2010) from national
tariffs. The literature search, conducted between July 2000 and July
2011, was performed by consulting PubMed e Ovid. Search terms used
were as follows:” Streptococcus pneumoniae”, “invasive
pneunmococcal diseases”, “Community-acquired pneumonia”, “cost”,
“economic”.
Results: The current analysis showed that hospitalization
represents the main cost driver. Regarding visits to GPs, annual
average cost was €53.9 per patient (€1.267.458 population). Regarding
diagnosis, annual average cost was €52,82 per patient (€1.242.062
population). Regarding drugs, antibiotic prescription absorbs a
significant amount of resources (€2.257.440 annually/patient).
Furthermore, the overall hospitalization costs due to Spn was
€175.837.848 annually.
Discussion: The analysis showed that the total cost due to Spn
diseases was more than €180 million annually. Nevertheless, this
value does not consider costs related to sequelae due to IPD and CAP,
because of a lack of data at national level. Therefore, it would be
necessary to conduct further analyses with the aim to investigate also
these costs in order to give a comprehensive picture of the costs
related to Spn diseases.
Implications for the health system/professionals/patients/
society: Considering the high costs due to streptococcal diseases it
would be necessary to consider the implementation of vaccination
strategies in the elderly population.
AB - Background: Streptococcus pneumoniae (Spn) is the most common
cause of Community-acquired pneumonia (CAP) and invasive
pneunmococcal diseases (IPD) in the elderly population.
Objectives: The objective of the analysis was to estimate the
economic burden of disease caused by Spn in Italy by considering
people aged > 65 years.
Methods: A cost of illness analysis was performed from the Italian
National Health Service (NHS) perspective. Therefore, only direct medical costs were taken into account. The main cost drivers were as
follows: diagnosis, visits to GPs, drugs, hospitalizations. Regarding
epidemiological and economic data input, incidence rates were taken
from the national literature and unit costs (€2010) from national
tariffs. The literature search, conducted between July 2000 and July
2011, was performed by consulting PubMed e Ovid. Search terms used
were as follows:” Streptococcus pneumoniae”, “invasive
pneunmococcal diseases”, “Community-acquired pneumonia”, “cost”,
“economic”.
Results: The current analysis showed that hospitalization
represents the main cost driver. Regarding visits to GPs, annual
average cost was €53.9 per patient (€1.267.458 population). Regarding
diagnosis, annual average cost was €52,82 per patient (€1.242.062
population). Regarding drugs, antibiotic prescription absorbs a
significant amount of resources (€2.257.440 annually/patient).
Furthermore, the overall hospitalization costs due to Spn was
€175.837.848 annually.
Discussion: The analysis showed that the total cost due to Spn
diseases was more than €180 million annually. Nevertheless, this
value does not consider costs related to sequelae due to IPD and CAP,
because of a lack of data at national level. Therefore, it would be
necessary to conduct further analyses with the aim to investigate also
these costs in order to give a comprehensive picture of the costs
related to Spn diseases.
Implications for the health system/professionals/patients/
society: Considering the high costs due to streptococcal diseases it
would be necessary to consider the implementation of vaccination
strategies in the elderly population.
KW - Cost
KW - Pneumonia
KW - Cost
KW - Pneumonia
UR - http://hdl.handle.net/10807/36539
M3 - Conference article
SN - 0213-9111
SP - 195
EP - 195
JO - Gaceta Sanitaria
JF - Gaceta Sanitaria
T2 - 9th HTAi Annual Meeting
Y2 - 23 June 2012 through 27 June 2012
ER -